Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Nov 26:4:340.
doi: 10.3389/fonc.2014.00340. eCollection 2014.

The Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and Progression

Affiliations
Review

The Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and Progression

Sebastiano Andò et al. Front Oncol. .

Abstract

Adipokines represent likely candidates to mediate the increased breast cancer risk and the enhanced progression associated with obesity. Other contributors to obesity-related cancer progression are insulin/IGF-1 pathways and hormones. Among these, the adipokine leptin is the most intensively studied in both metabolism in general and in cancer due to the fact that leptin levels increase in proportion of fat mass. Leptin is primarily synthesized from adipocytes but it is also produced by other cells including fibroblasts. In this latter case, it has been well demonstrated how cancer-associated fibroblasts express leptin receptor and secrete leptin, which sustains a short autocrine loop and is able to target tumor epithelial cells enhancing breast cancer cell motility and invasiveness. In addition, it has been reported that leptin may induce breast cancer to undergo a transition from epithelial to spindle-like mesenchymal morphology, activating the signaling pathways devoted to the EMT. Thus, it emerges how leptin may play a crucial role in mediating malignant cell and tumor microenvironment interactions. Here, we present an overview of the role of leptin in breast cancer, covering the following topics: (1) leptin as an amplifier of estrogen signaling in tumor epithelial cells contributing to the promotion of carcinogenesis; (2) leptin as a crucial player in mediating tumor-stroma interaction and influencing EMT-linked mechanisms, that may sustain breast cancer growth and progression; (3) leptin and leptin receptor targeting as novel therapeutic strategies for breast cancer treatment.

Keywords: EMT; breast cancer; estrogen receptor; leptin-signaling pathway; stem cells; tumor microenvironment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Endocrine, paracrine and autocrine actions of leptin. Leptin circulating at high levels in obesity impacts breast cancer initiation and progression in an endocrine manner. Leptin secreted by adipocytes and fibroblasts resident in breast tumor microenvironment acts on breast cancer cells in a paracrine fashion. Leptin produced by breast cancer cells supports tumor proliferation and invasion into the surrounding tissue through a short autocrine loop.

Similar articles

Cited by

References

    1. Arendt LM, Rudnick JA, Keller PJ, Kuperwasser C. Stroma in breast development and disease. Semin Cell Dev Biol (2009) 21:11–810.1016/j.semcdb.2009.10.003 - DOI - PMC - PubMed
    1. Aboussekhra A. Role of cancer-associated fibroblasts in breast cancer development and prognosis. Int J Dev Biol (2011) 55:841–9.10.1387/ijdb.113362aa - DOI - PubMed
    1. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature (2004) 432:332–710.1038/nature03096 - DOI - PMC - PubMed
    1. Barone I, Catalano S, Gelsomino L, Marsico S, Giordano C, Panza S. Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells. Cancer Res (2012) 72:1416–27.10.1158/0008-5472.CAN-11-2558 - DOI - PMC - PubMed
    1. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med (1996) 334:292–5.10.1056/NEJM199602013340503 - DOI - PubMed